awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26751302-DCE18020-A0BF-4CD1-8A49-356A7E779E86
Q26751302-DCE18020-A0BF-4CD1-8A49-356A7E779E86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751302-DCE18020-A0BF-4CD1-8A49-356A7E779E86
An overview on therapeutics attenuating amyloid β level in Alzheimer's disease: targeting neurotransmission, inflammation, oxidative stress and enhanced cholesterol levels
P2860
Q26751302-DCE18020-A0BF-4CD1-8A49-356A7E779E86
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26751302-DCE18020-A0BF-4CD1-8A49-356A7E779E86
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fa2c160618ae6aee4606ad8d002d289bd83e7776
P2860
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.